Vural A, Şimşir G, Tekgül Ş, Koçoğlu C, Akçimen F, Kartal E, Şen NE, Lahut S, Ömür Ö, Saner N, Gül T, Bayraktar E, Palvadeau R, Tunca C, Pirkevi Çetinkaya C, Gündoğdu Eken A, Şahbaz I, Kovancılar Koç M, Öztop Çakmak Ö, Hanağası H, Bilgiç B, Eraksoy M, Gündüz A, Apaydın H, Kızıltan G, Özekmekçi S, Siva A, Altıntaş A, Kaya Güleç ZE, Parman Y, Oflazer P, Deymeer F, Durmuş H, Şahin E, Çakar A, Tüfekçioğlu Z, Tektürk P, Çorbalı MO, Tireli H, Akdal G, Yiş U, Hız S, Şengün İ, Bora E, Serdaroğlu G, Erer Özbek S, Ağan K, İnce Günal D, Us Ö, Kurt SG, Aksoy D, Bora Tokçaer A, Elmas M, Gültekin M, Kumandaş S, Acer H, Kaya Özçora GD, Yayla V, Soysal A, Genç G, Güllüoğlu H, Kotan D, Özözen Ayas Z, Şahin HA, Tan E, Topçu M, Topçuoğlu ES, Akbostancı C, Koç F, Ertan S, Elibol B, Başak AN. The complex genetic landscape of hereditary ataxias in Turkey and implications in clinical practice. Mov Disord. 2021 Feb 24. doi: 10.1002/mds.28518. Online ahead of print.PMID: 33624863
Altıntaş A, Yildiz-Tas A, Yilmaz S, Bayraktutar BN, Comert MC, Zimmermann H, Brandt AU, Paul F, Sahin A. A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy.
Mult Scler J Exp Transl Clin. 2021 Mar 19;7(1):2055217321998060. doi: 10.1177/2055217321998060. eCollection 2021 Jan-Mar.PMID: 33796330
Yeh WZ, Widyastuti PA, Van der Walt A, Stankovich J, Havrdova E, Horakova D, Vodehnalova K, Ozakbas S, Eichau S, Duquette P, Kalincik T, Patti F, Boz C, Terzi M, Yamout BI, Lechner-Scott J, Sola P, Skibina OG, Barnett M, Onofrj M, Sá MJ, McCombe PA, Grammond P, Ampapa R, Grand’Maison F, Bergamaschi R, Spitaleri DLA, Van Pesch V, Cartechini E, Hodgkinson S, Soysal A, Saiz A, Gresle M, Uher T, Maimone D, Turkoglu R, Hupperts RM, Amato MP, Granella F, Oreja-Guevara C, Altintas A, Macdonell RA, Castillo-Trivino T, Butzkueven H, Alroughani R, Jokubaitis VG; MSBase Study Group. Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis. Neurology. 2021 Apr 20:10. 1212/WNL.0000000000012084. doi: 10.1212/WNL.0000000000012084. Online ahead of print.PMID: 33879599
Jokubaitis VG, Skibina O, Alroughani R, Altintas A, Butzkueven H, Eichau S, Fragoso Y, Hellwig K, Hughes SE, Rath L, van der Walt A, Gray O. The MSBase pregnancy, neonatal outcomes, and women’s health registry. Ther Adv Neurol Disord. 2021 Apr 12;14:17562864211009104. doi: 10.1177/17562864211009104. eCollection 2021.PMID: 33912245
Le M, Malpas C, Sharmin S, Horáková D, Havrdova E, Trojano M, Izquierdo G, Eichau S, Ozakbas S, Lugaresi A, Prat A, Girard M, Duquette P, Larochelle C, Alroughani R, Bergamaschi R, Sola P, Ferraro D, Grammond P, Grand’ Maison F, Terzi M, Boz C, Hupperts R, Butzkueven H, Pucci E, Granella F, Van Pesch V, Soysal A, Yamout BI, Lechner-Scott J, Spitaleri D, Ampapa R, Turkoglu R, Iuliano G, Ramo-Tello C, Sanchez-Menoyo JL, Sidhom Y, Gouider R, Shaygannejad V, Prevost J, Altintas A, Fragoso YD, McCombe PA, Petersen T, Slee M, Barnett MH, Vucic S, Van Der Walt A, Kalincik T. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis. Mult Scler. 2021 Apr;27(5):755-766. doi: 10.1177/1352458520926955. Epub 2020 Jun 15.PMID: 32538713
Moradi N, Sharmin S, Malpas C, Ozakbas S, Shaygannejad V, Terzi M, Boz C, Yamout B, Turkoglu R, Karabudak R, Hamdy S, Soysal A, Altıntaş A, Inshasi J, Al-Harbi T, Alroughani R, Kalincik T; MSBase Study Group. Utilization of Multiple Sclerosis therapies in the Middle East over a decade: 2009-2018. CNS Drugs. 2021 Jun 23. doi: 10.1007/s40263-021-00833-w. Online ahead of print.PMID: 34164782
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Long term safety and efficacy of Eculizumab in Aquaporin-4 IgG-positive NMOSD. Ann Neurol. 2021 Jun;89(6):1088-1098. Doi: 10.1002/ana.26049. Epub 2021 Feb 27.PMID: 33586143
Altintas A, Ersen-Danyeli A, Bozkurt SB, Uysal SP, Akpek S, Aygun MS, Akay OM, Kahyaoglu B, Peker S, Ure UB,Ferhanoglu B. A 52-Year-Old Man With Progressive Weakness and Incontinence. The Neurohospitalist. August 13, 2021. https://doi.org/10.1177/19418744211039586
Barnett M, Bergsland N, Weinstock-Guttman B, Butzkueven H, Kalincik T, Desmond P, Gaillard F, van Pesch V, Ozakbas S, Rojas JI, Boz C, Altintas A, Wang C, Dwyer MG, Yang S, Jakimovski D, Kyle K, Ramasamy DP, Zivadinov R. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study. Neuroimage Clin. 2021 Aug 24;32:102802. doi: 10.1016/j.nicl.2021.102802. Epub ahead of print. PMID: 34469848; PMCID: PMC8408519.
Oertel FC, Specovius S, Zimmermann HG, Chien C, Motamedi S, Bereuter C, Cook L, Lana Peixoto MA, Fontanelle MA, Kim HJ, Hyun JW, Palace J, Roca-Fernandez A, Leite MI, Sharma S, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, D’Cunha A, Aktas O, Ringelstein M, Albrecht P, May E, Tongco C, Leocani L, Pisa M, Radaelli M, Martinez-Lapiscina EH, Stiebel-Kalish H, Siritho S, de Seze J, Senger T, Havla J, Marignier R, Calvo AC, Bichuetti D, Tavares IM, Asgari N, Soelberg K, Altintas A, Yildirim R, Tanriverdi U, Jacob A, Huda S, Rimler Z, Reid A, Mao-Draayer Y, Soto de Castillo I, Petzold A, Green AJ, Yeaman MR, Smith T, Brandt AU, Paul F. Retinal Optical Coherence Tomography in Neuromyelitis Optica. Neurol Neuroimmunol Neuroinflamm. 2021 Sep 15;8(6):e1068. doi: 10.1212/NXI.0000000000001068. PMID: 34526385; PMCID: PMC8448522.
Yapıci-Eser Hale, Koroglu Y.E, Oztop-Cakmak Ozgur, Keskin O, Gursoy A, Gursoy- Ozdemir Y.Neuropsychiatric symptoms of COVID-19 explained by SARS- CoV-2 proteins,2 mimicry of human protein interactions. Front Hum. Neurosci.2021 Mar 23;15:656313. Doi:10.3389/fnhum.2021.656313.e Collection 2021
Tatiana Usnich , Eva-Juliane Vollstedt , Nathalie Schell , Volha Skrahina , Xenia Bogdanovic , Hanaa Gaber , Toni M. Förster , Andreas Heuer , Natalia Koleva- Alazeh , Ilona Csoti , Ayse Nazli Basak , Sibel Ertan , Gencer Genc , Peter Bauer , Katja Lohmann , Anne Grünewald , Emma L. Schymanski , Joanne Trinh , Susen Schaake , Daniela Berg , Doreen Gruber , Stuart H. Isaacson1, Andrea A. Kühn , Brit Mollenhauer, David J. Pedrosa, Kathrin Reetz , Esther M. Sammler , Enza Maria Valente, Franco Valzania, Jens Volkmann, Simone Zittel , Norbert Brüggemann, Meike Kasten, Arndt Rolfs, Christine Klein* and The LIPAD Study Group. LIPAD (LRRK2/Luebeck International Parkinson’s Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort. Front. Neurol., 09 August 2021 Doi: 10.3389/fneur.2021.710572
Özekmekçi S, Ertan S, Öztop Çakmak Ö, Peker S. Acute-onset hemiparkinsonism secondary to subacute-chronic subdural hematoma. Turkish Neurosurgery 2021 Doi: 10.5137/1019-5149.jtn.34459-21.1
Kılıç Ö, Yapıcı Eser H, Necef I, Altunoz U, Öztop Çakmak Ö, Aktaş C. How do physicians manage functional neurologic symptom disorder and somatic symptom disorder in the emergency department? A vignette study. Noropsikiatri Arşivi- Archives of Neuropsychiatry. Cil 58, sa.1,ss.1-7, 2021
Ulusoy C, Şekerdağ E, Yilmaz V, Yilmaz AB, Atak D, Vural A, Küçükali Cİ, Karaaslan Z, Kürtüncü M, Türkoğlu R, Özdemir YG, Tüzün E. Impact of Autoimmune Demyelinating Brain Disease Sera on Pericyte Survival. Noro Psikiyatr Ars. 2021 Jan 26;58(2):83-86. doi: 10.29399/npa.27350. PMID: 34188587; PMCID: PMC8214738.
Macrini C, Gerhards R, Winklmeier S, Bergmann L, Mader S, Spadaro M, Vural A, Smolle M, Hohlfeld R, Kümpfel T, Lichtenthaler SF, Franquelim HG, Jenne D, Meinl E. Features of MOG required for recognition by patients with MOG antibody-associated disorders. Brain. 2021 Sep 4;144(8):2375-2389. doi: 10.1093/brain/awab105. PMID: 33704436.
Özkan E, Gürsoy-Özdemir Y. Occipital bending in migraine with visual aura. Headache. 2021 Nov;61(10):1562-1567. doi: 10.1111/head.14240. Epub 2021 Nov 28. PMID: 34841519.
Heidarzadeh M, Gürsoy-Özdemir Y, Kaya M, Eslami Abriz A, Zarebkohan A, Rahbarghazi R, Sokullu E. Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls. Cell Biosci. 2021 Jul 22;11(1):142. doi: 10.1186/s13578-021-00650-0. PMID: 34294165; PMCID: PMC8296716.
Anwar MM, Özkan E, Gürsoy-Özdemir Y. The role of extracellular matrix alterations in mediating astrocyte damage and pericyte dysfunction in Alzheimer’s disease: A comprehensive review. Eur J Neurosci. 2021 Jun 28. doi: 10.1111/ejn.15372. Epub ahead of print. PMID: 34182602.
Özkan E, Çetin-Taş Y, Şekerdağ E, Kızılırmak AB, Taş A, Yıldız E, Yapıcı-Eser H, Karahüseyinoğlu S, Zeybel M, Gürsoy-Özdemir Y. Blood-brain barrier leakage and perivascular collagen accumulation precede microvessel rarefaction and memory impairment in a chronic hypertension animal model. Metab Brain Dis. 2021 Dec;36(8):2553-2566. doi: 10.1007/s11011-021-00767-8. Epub 2021 Jun 12. PMID: 34118020.
Le M, Malpas C, Sharmin S, Horáková D, Havrdova E, Trojano M, Izquierdo G, Eichau S, Ozakbas S, Lugaresi A, Prat A, Girard M, Duquette P, Larochelle C, Alroughani R, Bergamaschi R, Sola P, Ferraro D, Grammond P, Grand’ Maison F, Terzi M, Boz C, Hupperts R, Butzkueven H, Pucci E, Granella F, Van Pesch V, Soysal A, Yamout BI, Lechner-Scott J, Spitaleri D, Ampapa R, Turkoglu R, Iuliano G, Ramo-Tello C, Sanchez-Menoyo JL, Sidhom Y, Gouider R, Shaygannejad V, Prevost J, Altintas A, Fragoso YD, McCombe PA, Petersen T, Slee M, Barnett MH, Vucic S, Van Der Walt A, Kalincik T. Disability Outcomes of Early Cerebellar and Brainstem Symptoms in Multiple Sclerosis. Mult Scler. 2020 Jun 15:1352458520926955
Malpas CB, Manouchehrinia A, Sharmin S, Roos I, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Eichau S, Bergamachi R, Sola P, Ferraro D, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Maison FG, Ozakbas S, Van Pesch V, Granella F, Huppert D, Pucci E, Boz C, Sidhom Y, Gouider R, Spitaleri D, Soysal A, Petersen T, Verheul F, Karabudak R, Turkoglu R, Ramo-Tello C, Terzi M, Cristiano E, Slee M, McCombe P, Macdonell R, Fragoso Y, Olascoaga J, Altintas A, Olsson T, Butzkueven H, Hillert J, Kalincik T. Early clinical markers of aggressive multiple sclerosis. Brain; 2020 May 1;143(5):1400-1413.
Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A , Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M aND Hellwig K on behalf of the International Women in MS (iWiMS). Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord 2020, Vol. 13: 1–30. DOI: 10.1177/1756286420936166
Whittam DH, Karthikeayan V, E. Gibbons E, Kneen R, Chandratre S, Ciccarelli O, Hacohen Y, de Seze J, Deiva K, Hintzen RQ, Wildemann B, Jarius S, Kleiter I, Rostasy K, Huppke P, Hemmer B, Paul F, Aktas O, Pröbstel AK, Arrambide G, Tintore M, Amato MP, Nosadini M, Mancardi MM, Capobianco M, Illes Z, Siva A, Altintas A, Akman‑Demir G, Pandit L, Apiwattankul M, Hor JY, Viswanathan S, Qiu W, Kim HJ, Nakashima I, Fujihara K, Ramanathan S, Dale RC, Boggild M, Broadley S, Lana‑Peixoto MA, Sato DK, Tenembaum S, Cabre P, Wingerchuk DM, Weinshenker BG, Greenberg B, Matiello M, Klawiter EC, Bennett JL, Wallach AI, Kister I, Banwell BL, Traboulsee A, Pohl D, Palace J, Leite MI, Levy M, Marignier R, Solomon T, 1Lim M, Huda S, Jacob A. Treatment of MOG antibody associated disorders: results of an international survey. Journal of Neurologyhttps://doi.org/10.1007/s00415-020-10026-y
Kunchok, A., Malpas, C., Nytrova, P., Havrdova, E.K., Alroughani, R., Terzi, M., Yamout, B., Hor,J.Y., Karabudak, R., Boz, C., Ozakbas, S., Olascoaga, J., Simo, M., Granella, F., Patti, F., McCombe,P., Csepany, T., Singhal, B., Bergamaschi, R., Fragoso, Y., Al-Harbi, T., Turkoglu, R., Lechner-Scott,J., Laureys, G., Oreja-Guevara, C., Pucci, E., Sola, P., Ferraro, D., Altintas, A., Soysal, A., Vucic, S., Grand’Maison, F., Izquierdo, G., Eichau, S., Lugaresi, A., Onofrj, M., Trojano, M., Marriott, M.,Butzkueven, H., Kister, I., Kalincik, T. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder (2020) Multiple Sclerosis and Related Disorders, 38, art. no. 101868.DOI: 10.1016/j.msard.2019.101868
Sá, M.J., Soares dos Reis, R., Altintas, A., Celius, E.G., Chien, C., Comi, G., Graus, F., Hillert, J.,Hobart, J., Khan, G., Kissani, N., Langdon, D., Leite, M.I., Okuda, D.T., Palace, J., Papais-Alvarenga,R.M., Mendes-Pinto, I., Shi, F.-D.State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis (2020) Neurology and Therapy (article in press).DOI: 10.1007/s40120-020-00202-7
Tenembaum S, Yeh EA; Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC). Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis. Front Pediatr. 2020 Jun 25;8:339. doi: 10.3389/fped.2020.00339. PMID: 32671002; PMCID: PMC7330096
Altintas A, Dargvainiene J, Schneider-Gold C, Asgari N, Ayzenberg I, Ciplea AI, Junker R, Leypoldt F, Wandinger KP, Hellwig K. Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG). Ther Adv Neurol Disord. 2020 Aug 25;13:1756286420949808. doi: 10.1177/1756286420949808. PMID: 32922516; PMCID: PMC7450460.
Tutuncu M, Altintas A, Dogan BV, Uygunoglu U, Kale Icen N, Elmalı Karakaya A, Coban E, Alpaslan BG, Sosyal A. The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study. Acta Neurol Belg. 2020 Aug 31. doi: 10.1007/s13760-020-01476-2. Epub ahead of print. PMID: 32865702.
Roos I, Leray E, Frascoli F, Casey R, Brown JWL, Horakova D, Havrdova EK, Trojano M, Patti F, Izquierdo G, Eichau S, Onofrj M, Lugaresi A, Prat A, Girard M, Grammond P, Sola P, Ferraro D, Ozakbas S, Bergamaschi R, Sá MJ, Cartechini E, Boz C, Granella F, Hupperts R, Terzi M, Lechner-Scott J, Spitaleri D, Van Pesch V, Soysal A, Olascoaga J, Prevost J, Aguera-Morales E, Slee M, Csepany T, Turkoglu R, Sidhom Y, Gouider R, Van Wijmeersch B, McCombe P, Macdonell R, Coles A, Malpas CB, Butzkueven H, Vukusic S, Kalincik T; MSBase; OFSEP investigators. Delay from treatment start to full effect of immunotherapies for multiple sclerosis. Brain. 2020 Sep 1;143(9):2742-2756. doi: 10.1093/brain/awaa231.PMID: 32947619
Specovius S, Zimmermann HG, Oertel FC, Chien C, Bereuter C, Cook LJ, Lana Peixoto MA, Fontenelle MA, Kim HJ, Hyun JW, Jung SK, Palace J, Roca-Fernandez A, Diaz AR, Leite MI, Sharma SM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, Dcunha A, Aktas O, Ringelstein M, Albrecht P, May E, Tongco C, Leocani L, Pisa M, Radaelli M, Martinez-Lapiscina EH, Stiebel-Kalish H, Hellmann M, Lotan I, Siritho S, de Seze J, Senger T, Havla J, Marignier R, Tilikete C, Cobo Calvo A, Bichuetti DB, Tavares IM, Asgari N, Soelberg K, Altintas A, Yildirim R, Tanriverdi U, Jacob A, Huda S, Rimler Z, Reid A, Mao-Draayer Y, de Castillo IS, Yeaman MR, Smith TJ, Brandt AU, Paul F; GJCF International Clinical Consortium for NMOSD. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO). BMJ Open. 2020 Oct 29;10(10):e035397. doi: 10.1136/bmjopen-2019-035397. PMID: 33122310
Bovis F, Kalincik T, Lublin F, Cutter G, Malpas C, Horakova D, Havrdova EK, Trojano M, Prat A, Girard M, Duquette P, Onofrj M, Lugaresi A, Izquierdo G, Eichau S, Patti F, Terzi M, Grammond P, Bergamaschi R, Sola P, Ferraro D, Ozakbas S, Iuliano G, Boz C, Hupperts R, Grand’Maison F, Oreja-Guevara C, van Pesch V, Cartechini E, Petersen T, Altintas A, Soysal A, Ramo-Tello C, McCombe P, Turkoglu R, Butzkueven H, Wolinsky JS, Solaro C, Sormani MP. Treatment response score to glatiramer acetate or interferon beta-1a. Neurology. 2021 Jan 12;96(2):e214-e227. doi: 10.1212/WNL.0000000000010991. Epub 2020 Oc 6. PMID: 33024022
Cakmak YO, Ozsoy B, Ertan S, Öztop-Çakmak Ö, Kiziltan G, Yapici-Eser H, Ozyaprak E, Olcer S, Urey H, Gursoy-Özdemir Y. Intrinsic Auricular Muscle Zone Stimulation Improves Walking Parameters of Parkinson’s Patients Faster than Levodopa in the Motion Capture Analysis: A pilot study .Frontiers in Neurology, section Movement Disorders Doi: 1010.3389/fneur.2020.546123
Eren İ, Abay B, Günerbüyük C, Çakmak ÖÖ, Şar C, Demirhan M. Spinal fusion in fascioscapulohumeral dystrophy for hyperlordosis: A case resport. Medicine (Baltimore). 2020 Feb; 99(8) e18787. Doi: 10.1097/ MD.0000000000018787. PIMID: 32080072
ÖzsezerY,ErtanS.F,YararO,AkakınA,YılmazA,CakirM,CeylanM,Oztop- Cakmak O, Beyazıt Y.G. The cost Benefit and Effectiveness Analyse of DBS Theraphy on Parkinson’s disease in Four Different University Hospital in Turkey. Health Science of Journal. June 1 2020. DOI: 10.36648/1791-809X.14.2.719
AlayliogluM,DursunE,GençG,ŞengülB,BilgiçB,GündüzA,ApaydınH,Kızıltan G, Gürvit H, Hanağası H, Öztop Çakmak Ö, Ertan S, Yılmazer S, Gezen-Ak D. Genetic Variants of Vitamin D Metabolism- Related DHCR7/ NADSYN1 locus and CYP2R1 Gene are Associated wit Clinical Features of Parkinosn’s disease. International Journal of Neuroscience (INESS) 2020 Sep 16:1-11 DOI:10.1080/00207454.2020.1820502
PalvadeauR,Kaya-GüleçZ.E.,ŞimşirG,VurlaA,Öztop-ÇakmakÖ,GençG, S.Aygün M:S:, Falay O, Nazlı Basak A, Ertan S. Cereballar cognitive-affective syndrome preceding ataxia associated with complex extrapyramidal features in a Turkish SCA48 familiy. Neurogenetics 2020 Jan; (21)(1):57-58 doi:10.1007/s10048-019-00595-0
Erenİ,BirselO, ÖztopÇakmakÖ, AslangerA, GürsoyÖzdemirY, EraslanS, Kayserili H, Oflazer P, Demirhan M. A novel shoulder disability staging system for scapulothorasic arthrodesis in patients with fascioscapulohumeral dystrophy. Orthop Traumatol surg Res. 2020 Jun; 106 (4): 701-707. Doi: 10.1016/j. Otsr.2020.03.002.Epub 2020 May16. PMID: 32430271
Karahuseyinoglu S, Sekerdag E, Aria MM, Cetin Tas Y, Nizamoglu S, Solaroglu I, Gürsoy-Özdemir Y. Three-dimensional neuron-astrocyte construction on matrigel enhances establishment of functional voltage-gated sodium channels. J Neurochem. 2021 Mar;156(6):848-866. doi: 10.1111/jnc.15185. Epub 2020 Sep 30. PMID: 32939791.
Inan B, Gocmen R, Vural A, Colpak AI, Meinl E, Karabudak R, Tuncer A. Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from Turkey. Mult Scler Relat Disord. 2020 Sep;44:102376. doi: 10.1016/j.msard.2020.102376. Epub 2020 Jul 4. Erratum in: Mult Scler Relat Disord. 2021 Feb;48:102581. PMID: 32674059.
Vural A, Derle E, Sayat-Gürel G, Karabudak R, Tuncer A. Predictors of progression in primary progressive multiple sclerosis in a large Turkish cohort. Mult Scler Relat Disord. 2020 Feb;38:101520. doi: 10.1016/j.msard.2019.101520. Epub 2019 Nov 12. PMID: 31743849.
Hanoğlu L, Ercan FB, Mantar N, Helvacı Yılmaz N, Sitrava S, Özer F, Yuluğ B. Accelerated forgetting and verbal memory consolidation process in idiopathic nondement Parkinson’s disease. J Clin Neurosci. 2019 Dec;70:208-213. doi: 10.1016/j.jocn.2019.08.012. Epub 2019 Aug 28
Kunchok A, Malpas C, Nytrova P, Havrdova EK, Alroughani R, Terzi M, Yamout B, Hor JY, Karabudak R, Boz C, Ozakbas S, Olascoaga J, Simo M, Granella F, Patti F, McCombe P, Csepany T, Singhal B, Bergamaschi R, Fragoso Y, Al-Harbi T, Turkoglu R, Lechner-Scott J, Laureys G, Oreja-Guevara C, Pucci E, Sola P, Ferraro D, Altintas A, Soysal A, Vucic S, Grand’Maison F, Izquierdo G, Eichau S, Lugaresi A, Onofrj M, Trojano M, Marriott M, Butzkueven H, Kister I, Kalincik T. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2019 Nov 25;38:101868. doi: 10.1016/j.msard.2019.101868. [Epub ahead of print]. PMID: 31877445.
Zhou Y, Claflin SB, Stankovich J, van der Mei I, Simpson S Jr, Roxburgh RH, Kalincik T, Blizzard L, Lugaresi A, Alroughani R, Sajedi SA, Butzkueven H, Pucci E, Spitaleri D, Granella F, Cristiano E, Yamout B, Hughes S, Gouider R, Sánchez Menoyo JL, Olascoaga J, McGuigan C, Shaw C, Kermode AG, Kasa K, Al-Harbi T, Altintas A, Laureys G, Fragoso Y, Hardy TA, Csepany T, Sirbu CA, Decoo D, Sas A, Alvarez-Cermeño JC, Kotkata K, Millán-Pascual J, Taylor BV. Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype. Mult Scler. 2019 Oct 31;1352458519881994. doi: 10.1177/1352458519881994. [Epub ahead of print]. PMID: 31668127.
Tahrali I, Kucuksezer UC, Akdeniz N, Altintas A, Uygunoglu U, Aktas-Cetin E, Deniz G. CD3-CD56+ NK cells display an inflammatory profile in RR-MS patients. Immunol Lett. 2019 Dec;216:63-69. doi: 10.1016/j.imlet.2019.10.006. Epub 2019 Oct 4. PMID: 31589897.
Boz C, Terzi M, Özer B, Turkoglu R, Karabudak R, Efendi H, Soysal A, Sevim S, Altintas A, Kurne A, Akçalı A, Akman G, Yüceyar N, Balcı BP, Ekmekci Ö, Karahan SZ, Demirkıran M, Altunrende B, Turan ÖF, Gökçen GözübatıkÇelik, Kale N, Köseoğlu M, Ozakbas S. Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2019 Nov;36:101376. doi: 10.1016/j.msard.2019.101376. Epub 2019 Aug 26. PMID: 31473488.
CE Leurs, HAM Twaalfhoven, BI Lissenberg-Witte, V van Pesch, I Dujmovic, J Drulovic, M Castellazzi , T Bellini, M Pugliatti, J Kuhle, LM Villar, JC Alvarez-Cermeño, R Alvarez-Lafuente , H Hegen, F Deisenhammer , LM Walchhofer, E Thouvenot, M Comabella, X Montalban, L Vécsei, C Rajda, D Galimberti, E Scarpini, A Altintas, K Rejdak, JL Frederiksen, G Pihl-Jensen, PEH Jensen, M Khalil , MM Voortman , F Fazekas, A Saiz , D La Puma, M Vercammen, L Vanopdenbosch, BMJ Uitdehaag, J Killestein, C Bridel and C Teunissen. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study. Mult Scler. 2019 May 8:1352458519845844
Öztop-Çakmak Ö , Vanli-Yavuz E , Aygün S , Bastan B , Egemen E , Solaroğlu I , Gursoy-Ozdemir Y . Isolated hypoglossal nerve palsy due to a jugular foramen schwannoma. A foramen jugulare schwannomája következtében kialakuló izolált nervus hypoglossus bénulás. Ideggyogy Sz. 2019 Jul 30;72(7-8):282-284. English. doi: 10.18071/isz.72.0282. PMID: 31517462.
Aydin K, Barburoglu M, Oztop Cakmak O, Yesilot N, Vanli ENY, Akpek S. Crossing Y-Solitaire thrombectomy as a rescue treatment for refractory acute occlusions of the middle cerebral artery. J Neurointerv Surg. 2019 Mar;11(3):246-250. doi: 10.1136/neurintsurg-2018-014288. Epub 2018 Sep 7. PMID: 30194110.
Dinçer Y, Akkaya Ç, Mutlu T, Yavuzer S, Erkol G, Bozluolcay M, Guven M. DNA repair gene OGG1 polymorphism and its relation with oxidative DNA damage in patients with Alzheimer’s disease. Neurosci Lett. 2019 Sep 14;709:134362. doi: 10.1016/j.neulet.2019.134362. Epub 2019 Jul 9. PMID: 31299287.
Palvadeau R, Kaya-Güleç ZE, Şimşir G, Vural A, Öztop-Çakmak Ö, Genç G, Aygün MS, Falay O, Başak AN, Ertan S. Cerebellar cognitive-affective syndrome preceding ataxia associated with complex extrapyramidal features in a Turkish SCA48 family. Neurogenetics. 2020 Jan;21(1):51-58. doi: 10.1007/s10048-019-00595-0. Epub 2019 Nov 19. PMID: 31741143.
Elmali AD, Simsekoglu R, Sahin E, Duman Ilki C, Uygun O, Coban O, Gurses C. Senile-Onset Subacute Sclerosing Panencephalitis, Presenting With Peculiar Findings. Clin EEG Neurosci. 2019 Jul;50(4):283-286. doi: 10.1177/1550059418793758. Epub 2018 Aug 13. PMID: 30099908.
Eren İ, Erşen A, Birsel O, Atalar AC, Oflazer P, Demirhan M. Functional Outcomes and Complications Following Scapulothoracic Arthrodesis in Patients with Facioscapulohumeral Dystrophy. J Bone Joint Surg Am. 2019 Oct 25;10.2106/JBJS.19.00571. doi: 10.2106/JBJS.19.00571. [Epub ahead of print]. PMID: 31658207.
Taş YÇ, Solaroğlu İ, Gürsoy-Özdemir Y. Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance. Curr Neuropharmacol. 2019;17(2):151-164. doi: 10.2174/1570159X15666170915160707. PMID: 28925885; PMCID: PMC6343201.
Vural A, Derle E, Sayat-Gürel G, Karabudak R, Tuncer A. Predictors of progression in primary progressive multiple sclerosis in a large Turkish cohort. Mult Scler Relat Disord. 2019 Nov 12;38:101520. doi: 10.1016/j.msard.2019.101520. [Epub ahead of print]. PMID: 31743849.
Winklmeier S, Schlüter M, Spadaro M, Thaler FS, Vural A, Gerhards R, Macrini C, Mader S, Kurne A, Inan B, Karabudak R, Özbay FG, Esendagli G, Hohlfeld R, Kümpfel T, Meinl E. Identification of circulating MOG-specific B cells in patients with MOG antibodies. Neurol Neuroimmunol Neuroinflamm. 2019 Oct 14;6(6):625. doi: 10.1212/NXI.0000000000000625. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2019 Nov 15;7(1):. PMID: 31611268; PMCID: PMC6857907.
Stengel H, Vural A, Brunder AM, Heinius A, Appeltshauser L, Fiebig B, Giese F, Dresel C, Papagianni A, Birklein F, Weis J, Huchtemann T, Schmidt C, Körtvelyessy P, Villmann C, Meinl E, Sommer C, Leypoldt F, Doppler K. Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5):e603. doi: 10.1212/NXI.0000000000000603. PMID: 31454780; PMCID: PMC6705632.
Akçimen F, Vural A, Durmuş H, Çakar A, Houlden H, Parman YG, Nazlı Başak A. A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID. J Hum Genet. 2019 Nov;64(11):1141-1144. doi: 10.1038/s10038-019-0652-y. Epub 2019 Aug 17. PMID: 31420593.
Marti Fernandez I, Macrini C, Krumbholz M, Hensbergen PJ, Hipgrave Ederveen AL, Winklmeier S, Vural A, Kurne A, Jenne D, Kamp F, Gerdes LA, Hohlfeld R, Wuhrer M, Kümpfel T, Meinl E. The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients. Front Immunol. 2019 Jun 11;10:1189. doi: 10.3389/fimmu.2019.01189. PMID: 31244828; PMCID: PMC6579858.
Güntekin B, Hanoğlu L, Güner D, Yılmaz NH, Çadırcı F, Mantar N, Aktürk T, Emek-Savaş DD, Özer FF, Yener G, Başar E. Cognitive Impairment in Parkinson’s Disease Is Reflected with Gradual Decrease of EEG Delta Responses during Auditory Discrimination. Front Psychol. 2018 Feb 21;9:170. doi: 10.3389/fpsyg.2018.00170.
Cakmak ÖÖ , Eren I , Aslanger A , Günerbüyük C , Kayserili H , Oflazer P , Sar C , Demirhan M , Özdemir YG . A multidisciplinary clinical approach to facioscapulohumeral muscular dystrophy. A facioscapulohumeralis muscularis dystrophia kezelésének multidiszciplináris megközelítése. Ideggyogy Sz. 2018 Sep 30;71(9-10):337-342. English. doi: 10.18071/isz.71.0337. PMID: 30335266.
Börü ÜT, Bilgiç AB, Köseoğlu Toksoy C, Yılmaz AY, Tasdemir M, Sensöz NP, Öztop Çakmak Ö, Duman A, Bölük C. Prevalence of Multiple Sclerosis in a Turkish City Bordering an Iron and Steel Factory. J Clin Neurol. 2018 Apr;14(2):234-241. doi: 10.3988/jcn.2018.14.2.234. PMID: 29629528; PMCID: PMC5897208.
Kucuk M, Ugur Yilmaz C, Orhan N, Ahishali B, Arican N, Elmas I, Gürses C, Kaya M. The Effects of Lipopolysaccharide on the Disrupted Blood-Brain Barrier in a Rat Model of Preeclampsia. J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3411-3418. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.003. Epub 2018 Sep 12. PMID: 30217638.
Mehdikhanova L, Vanli Yavuz EN, Çikrikçili U, Baral Kulaksizoğlu I, Bebek N, Gürses C, Gökyiğit A, Baykan B. Investigation of the Video-EEG Findings and Clinical Data in Patients Diagnosed With Epilepsy and Psychosis. Neurologist. 2018 Sep;23(5):167-174. doi: 10.1097/NRL.0000000000000195. PMID: 30169371.
Baykan B, Gungor Tuncer O, Vanli-Yavuz EN, Baysal Kirac L, Gundogdu G, Bebek N, Gurses C, Altindag E, Tuzun E. Delta Brush Pattern Is Not Unique to NMDAR Encephalitis: Evaluation of Two Independent Long-Term EEG Cohorts. Clin EEG Neurosci. 2018 Jul;49(4):278-284. doi: 10.1177/1550059417693168. Epub 2017 Feb 16. PMID: 29161898.
Eren İ, Erşen A, Birsel O, Atalar AC, Oflazer P, Demirhan M. Functional Outcomes and Complications Following Scapulothoracic Arthrodesis in Patients with Facioscapulohumeral Dystrophy. J Bone Joint Surg Am. 2019 Oct 25;10.2106/JBJS.19.00571. doi: 10.2106/JBJS.19.00571. [Epub ahead of print]. PMID: 31658207.
Sekerdag E, Solaroglu I, Gursoy-Ozdemir Y. Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options. Curr Neuropharmacol. 2018;16(9):1396-1415.
Kilic K, Karatas H, Dönmez-Demir B, Eren-Kocak E, Gursoy-Ozdemir Y, Can A, Petit JM, Magistretti PJ, Dalkara T. Inadequate brain glycogen or sleep increases spreading depression susceptibility. Ann Neurol. 2018 Jan;83(1):61-73. doi: 10.1002/ana.25122. PMID: 29244233.
Dönmez-Demir B, Yemisci M, Kılıç K, Gürsoy-Özdemir Y, Söylemezoğlu F, Moskowitz M, Dalkara T. Microembolism of single cortical arterioles can induce spreading depression and ischemic injury; a potential trigger for migraine and related MRI lesions. Brain Res. 2018 Jan 15;1679:84-90. doi: 10.1016/j.brainres.2017.11.023. Epub 2017 Nov 26. PMID: 29183666.
Vural A, Okar S, Kurne A, Sayat-Gürel G, Acar NP, Karabulut E, Oğuz KK, Kadayıfçılar S, Karabudak R. Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome. Mult Scler. 2018 Dec 11;1352458518817987. doi: 10.1177/1352458518817987. [Epub ahead of print]. PMID: 30526302.
Vural A, Doppler K, Meinl E. Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance. Front Immunol. 2018 May 14;9:1029. doi: 10.3389/fimmu.2018.01029. PMID: 29867996; PMCID: PMC5960694.
Vural S, Vural A, Akçimen F, Bağci IS, Tunca C, Gündoğdu Eken A, Ruzicka T, Başak AN. Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome. Int J Dermatol. 2018 Jul;57(7):843-848. doi: 10.1111/ijd.14013. Epub 2018 Apr 27. PMID: 29704247.
Kocoglu C, Gundogdu A, Kocaman G, Kahraman-Koytak P, Uluc K, Kiziltan G, Caglayan AO, Bilguvar K, Vural A, Basak AN. Homozygous CAPN1 mutations causing a spastic-ataxia phenotype in 2 families. Neurol Genet. 2018 Jan 18;4(1):e218. doi: 10.1212/NXG.0000000000000218. PMID: 29379883; PMCID: PMC5773845.
Kaya Y, Ozer F, Benli E, Yilmaz NH, Aydemir T, Demir EY. Evaluation of sexual dysfunction in Parkinson’s disease between two different regions of Turkey. Clin Neurol Neurosurg. 2017 Oct;161:117-120. doi: 10.1016/j.clineuro.2017.08.014. Epub 2017 Aug 30. PubMed PMID: 28869860.
Padir Şensöz N, Türk Börü Ü, Bölük C, Bilgiç A, Öztop Çakmak Ö, Duman A, Taşdemir M. Stroke epidemiology in Karabük city Turkey: Community based study. eNeurologicalSci. 2017 Dec 21;10:12-15. doi: 10.1016/j.ensci.2017.12.003. PMID: 29736423; PMCID: PMC5933997.
Oztop-Cakmak O, Solaroglu I, Gursoy-Ozdemir Y. The Role of Pericytes in Neurovascular Unit: Emphasis on Stroke. Curr Drug Targets. 2017;18(12):1386-1391. doi: 10.2174/1389450117666160613104523. PMID: 27296313.
Colpak AI, Balci-Peynircioglu B, Can A, Gursoy-Ozdemir Y, Lule S, Kalyoncu U, Dalkara T. Data of indirect immunofluorescence labeling of the mouse brain sections with sera from SLE and MS patients. Data Brief. 2017 Sep 20;15:170-173. doi: 10.1016/j.dib.2017.09.027. PMID: 29034286; PMCID: PMC5633813.
Lule S, Colpak AI, Balci-Peynircioglu B, Gursoy-Ozdemir Y, Peker S, Kalyoncu U, Can A, Tekin N, Demiralp D, Dalkara T. Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger. J Autoimmun. 2017 Nov;84:87-96.
Sekerdag E, Lüle S, Bozdağ Pehlivan S, Öztürk N, Kara A, Kaffashi A, Vural I, Işıkay I, Yavuz B, Oguz KK, Söylemezoğlu F, Gürsoy-Özdemir Y, Mut M. A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles. J Control Release. 2017 Sep 10;261:187-19
Akkaya Ç, Yavuzer SS, Yavuzer H, Erkol G, Bozluolcay M, Dinçer Y. DNA damage, DNA susceptibility to oxidation and glutathione redox status in patients with Alzheimer’s disease treated with and without memantine. J Neurol Sci. 2017 Jul 15;378:158-162. doi: 10.1016/j.jns.2017.04.051. Epub 2017 May 2. PubMed PMID:28566155.
Baştan B, Günaydin S, Balci FB, Acar H, Mutlu A, Özer F, Çokar Ö. Ischemic Stroke in the Elderly: Septuagenarians Versus Octogenarians. Noro Psikiyatr Ars. 2016 Dec;53(4):334-337. doi: 10.5152/npa.2016.15923. Epub 2016 Dec 1. PubMed PMID: 28360808; PubMed Central PMCID: PMC5353040.
Benli E, Özer FF, Kaya Y, Özcan TŞ, Ayyıldız A. Is there a difference between Parkinson disease patients and a control group in terms of urinary symptoms and quality of life? Turk J Med Sci. 2016 Dec 20;46(6):1665-1671. doi:10.3906/sag-1507-148. PubMed PMID: 28081354.
Günaydın ZY, Bektaş O, Karagöz A, Özer FF. Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease. Wien Klin Wochenschr. 2016 Jul;128(13-14):528-33. doi: 10.1007/s00508-016-1026-5. Epub 2016 Jun 24. PubMed PMID: 27343084.
Özcan T, Benli E, Özer F, Demir EY, Kaya Y, Ayyıldız A. The association between symptoms of sexual dysfunction and age at onset in Parkinson’s disease. Clin Auton Res. 2016 Jun;26(3):205-9. doi: 10.1007/s10286-016-0356-8. Epub 2016 May 17. PubMed PMID: 27188193.
Günaydın ZY, Özer FF, Karagöz A, Bektaş O, Karataş MB, Vural A, Bayramoğlu A, Çelik A, Yaman M. Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment. J Geriatr Cardiol. 2016 Jan;13(1):75-80. doi: 10.11909/j.issn.1671-5411.2016.01.003. PubMed PMID: 26918017; PubMed Central PMCID: PMC4753016.
Yapıcı-Eser H, Onay A, Öztop-Çakmak Ö, Egemen E, Vanlı-Yavuz EN, Solaroğlu İ. Rare case of glioblastoma multiforme located in posterior corpus callosum presenting with depressive symptoms and visual memory deficits. BMJ Case Rep. 2016 Dec 15;2016:bcr2016216505. doi: 10.1136/bcr-2016-216505. PMID: 27979842; PMCID: PMC5175
Onder H, Gursoy Ozdemir Y. Re: “Report of Dramatic Improvement after a Lumboperitoneal Shunt Procedure in a Case of Anticoagulation Therapy-Resistant Cerebral Venous Thrombosis”. J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1557-8
Lee J, Gursoy-Ozdemir Y, Fu B, Boas DA, Dalkara T. Optical coherence tomography imaging of capillary reperfusion after ischemic stroke. Appl Opt. 2016 Nov 20;55(33):9526-9531
Bozluolcay M, Andican G, Fırtına S, Erkol G, Konukoglu D. Inflammatory hypothesis as a link between Alzheimer’s disease and diabetes mellitus. Geriatr Gerontol Int. 2016 Oct;16(10):1161-1166. doi: 10.1111/ggi.12602. Epub 2015 Sep 3. PubMed PMID: 26337250.